case_images: PMC5320815_01
case_images: Chest X-ray revealed a left side pleural effusion
case_images: JNSBM-8-130-g001.jpg
case_images: PMC5320815_01_JNSBM-8-130-g001.jpg
case_images: F1
case_images: Chest X-ray showed the left side pleural effusion [Figure 1].
case_images: Chest computed tomography scan showed a loculated left pleural effusion with associated pleural thickening and adjacent atelectatic changes and no evidence of lymphadenopathy or parenchymal lung involvement
case_images: JNSBM-8-130-g002.jpg
case_images: PMC5320815_01_JNSBM-8-130-g002.jpg
case_images: F2
case_images: Chest computed tomography (CT) scan showed a loculated left pleural effusion with associated pleural thickening and adjacent atelectatic changes and no evidence of lymphadenopathy or parenchymal lung involvement [Figure 2].
case_images: Diffuse increased hepatic attenuation consistent with amiodarone hepatotoxicity
case_images: JNSBM-8-130-g003.jpg
case_images: PMC5320815_01_JNSBM-8-130-g003.jpg
case_images: F3
case_images: In addition, diffuse increased hepatic attenuation, with an average of 110 Hounsfield units (HU) (normal attenuation in the liver: 30-70 HU), was noted on the lower chest CT scan images, consistent with amiodarone hepatotoxicity [Figure 3].
case_images: Three months after amiodarone dose reduction and prednisone tapering, the patient was asymptomatic and a follow-up chest computed tomography scan showed significant improvement of the effusion
case_images: JNSBM-8-130-g004.jpg
case_images: PMC5320815_01_JNSBM-8-130-g004.jpg
case_images: F4
case_images: Three months after amiodarone dose reduction and prednisone tapering, the patient was asymptomatic and a follow-up chest CT scan showed significant improvement of the effusion [Figure 4].